Prostamax 20 mg
Main Image

Prostamax 20 mg

Steroids Dragon Pharma Peptides

$70.00

Dragon Pharma Prostamax 20 mg – Synthetic Tetrapeptide for Prostate Cell Research

✔ Synthetic KEDP tetrapeptide bioregulator ✔ Khavinson peptide class compound ✔ Studied for cellular signaling & chromatin dynamics ✔ USA domestic shipping available

Dragon Pharma Prostamax 20 mg is a synthetic tetrapeptide bioregulator with the amino acid sequence Lys-Glu-Asp-Pro (KEDP). As part of the well-characterized Khavinson peptide family, this compound has been investigated in laboratory settings for its role in cellular signaling, chromatin decondensation, and tissue-specific responses in prostate cell cultures.

Each vial contains 20 mg of lyophilized Prostamax in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Prostamax represents a targeted research tool for investigating prostate cell biology, gene expression regulation, and the molecular mechanisms underlying tissue-specific responses. For related research compounds, explore our peptides category and specifically Epitalon 50 mg for complementary cellular regulation studies.

What Makes Prostamax Valuable in Research?

Prostamax belongs to a class of short-chain peptides known for their tissue-specific bioregulatory properties. The KEDP sequence has been studied for its ability to influence cellular processes relevant to prostate biology, including chromatin remodeling, gene expression modulation, and cell signaling pathways. Its defined sequence and mechanism of action make it a practical tool for investigating the molecular basis of prostate cell function and regulation.

Researchers value Prostamax for its targeted approach to studying prostate cell biology. Its ability to modulate chromatin structure and cellular signaling provides insights into the mechanisms that govern tissue-specific responses and gene regulation. For investigators exploring other areas of cellular regulation, Livagen 20 mg offers complementary research avenues in chromatin remodeling and gene expression studies.

Current scientific literature on Khavinson peptides, including Prostamax, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.

Key Research Applications for Dragon Pharma Prostamax

  • ✔ Investigation of prostate cell signaling pathways
  • ✔ Evaluation of chromatin decondensation mechanisms
  • ✔ Research on tissue-specific gene expression regulation
  • ✔ Studies of peptide bioregulation in prostate models
  • ✔ Preclinical models of prostate cell function and response
For Research Purposes Only

Prostamax 20 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on cellular signaling, Ovagen 20 mg provides additional research avenues in tissue-specific peptide regulation.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Dragon Pharma
Manufacturer: Dragon Pharma
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines</h2> <div class="info-card warning"> <p><strong>For research and laboratory use only.</strong> Dragon Pharma Prostamax 20 mg is a synthetic tetrapeptide bioregulator. Proper reconstitution, handling, and experimental design are essential for obtaining reliable data.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Use sterile bacteriostatic water for injection</li> <li>✔ Add appropriate volume to achieve desired concentration</li> <li>✔ Swirl gently to dissolve – do not shake vigorously</li> <li>✔ Store reconstituted solution at 2–8°C</li> </ul> <p>Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 20 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.</p> <h3>Typical Research Parameters</h3> <p>In research settings, Prostamax is typically administered via subcutaneous or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.</p> <ul> <li>✔ Commonly used in prostate cell signaling studies</li> <li>✔ Often combined with histological and molecular analysis</li> <li>✔ Used to investigate chromatin remodeling and gene expression</li> <li>✔ Research models include prostate cell cultures and tissue studies</li> </ul> <h3>Factors to Consider in Research Protocols</h3> <ul> <li>Short-chain peptide with specific bioregulatory properties</li> <li>Reconstitution stability is limited; prepare fresh solutions for each use</li> <li>Individual variation in response may be observed across subjects</li> <li>Storage conditions significantly impact peptide stability</li> </ul> <div class="info-card"> <p><strong>Research note:</strong> Prostamax is part of the Khavinson peptide class, known for their tissue-specific bioregulatory effects. Its short KEDP sequence provides a defined molecular tool for investigating prostate cell biology, chromatin dynamics, and cellular signaling pathways in preclinical models.</p> </div> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Synthetic Linear Tetrapeptide
Peptide Sequence
Lys-Glu-Asp-Pro (KEDP)
Peptide Length
4 Amino-Acid Residues
Terminal Form
H-Lys-Glu-Asp-Pro-OH
Molecular Formula
C₂₀H₃₃N₅O₉
Molecular Weight
487.5 g/mol
CAS Number
473578-47-1
PubChem CID
9848296
Sequence Code
KEDP
Research Status
Experimental / Preclinical

Chat on WhatsApp